News

'I'm hoping we get a pullback': Morgan Stanley's CIO says any potential tariff-fueled drop in stocks is a buying opportunity
"This is what the beginning of a new bull market looks like," Morgan Stanley's CIO said, adding that earnings look resilient ...
Morgan Stanley evaluates acquisitions, but sets a high bar for deals, CEO says
Morgan Stanley CEO Ted Pick, who runs one of Wall Street's biggest dealmakers, said his own firm was considering acquisitions ...
Morgan Stanley Wealth Unit Delivers Strong Performance in Volatile Quarter
Morgan Stanley’s wealth management business lifted the company’s earnings the second quarter, which was marked by President ...
GlobalData on MSN1d
Morgan Stanley’s revenue and net income increase in Q2 2025
Financial services company Morgan Stanley has reported net revenues of $16.8bn for the second quarter (Q2) ending 30 June ...
Trump’s tariffs are turning into a ‘mosaic’ that will be ‘idiosyncratic,’ Morgan Stanley says, projecting a $2.7 trillion haul over 10 years
The average effective tariff rate has been around 16%, Morgan Stanley Wealth Management calculates, 5 times higher than the ...
ABP News on MSN4h
Morgan Stanley Projects Another Rate Cut In October As Inflation Cools In India
In its latest research report, Morgan Stanley said consumer price index (CPI) inflation has been consistently falling below 4 per cent since February this year ...
Explore more
Companies have a good deal of cushion to absorb tariff costs, says Morgan Stanley's Ellen Zentner
Ellen Zentner, Morgan Stanley, joins 'Closing Bell' to discuss Zentner's thoughts on the economy, how the Federal Reserve ...
Morgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating
United Therapeutics Corporation (NASDAQ:UTHR) is one of the high-margin pharma stocks to buy now. Morgan Stanley has lowered its price target on United Therapeutics (NASDAQ: UTHR) to $328 from $348, ...